# US 2025/0152623 A1 · Compositions and kits for use in wound healing, tissue regeneration and/or bone regeneration

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0152623 A1
- Document ID: US20250152623A1
- Status: Published application
- Kind: A1
- Application number: 18/836,398
- Filed: 2023-02-16
- Published: 2025-05-15
- Earliest claimed: 2022-02-16
- Assignees: Universitätsmedizin der Johannes Gutenberg-Universität Mainz
- Applicants: Universitätsmedizin der Johannes Gutenberg-Universität Mainz
- Inventors: Lena Katharina Müller-Heupt; John Eckelt
- Web page: https://patentgrep.com/patent/US20250152623A1

## CPC

- A61K 31/728: Hyaluronic acid
- A61K 33/40: Peroxides
- A61K 33/08: Oxides; Hydroxides
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61P 1/02: Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A61P 31/04: Antibacterial agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Many next-generation biomaterials will need the ability to not only promote healthy tissue integration but to simultaneously resist bacterial colonization and resulting biomaterials-associated infection. For this purpose, antimicrobial nanofibers of polycaprolactone (PCL) were fabricated by incorporating calcium peroxide. PCL nanofibers containing different ratios of calcium peroxide (1%, 5% and 10% (w/w)) with or without ascorbic acid were fabricated using an electrospinning technique. Antimicrobial evaluations confirmed the inhibitory properties of the nanofibers on the growth of E. coli and S. epidemidis because of a significant burst release of calcium peroxide from the nanofibers. Analysis of tissue cell response showed that despite an initial toxic effect over the first 24 h, after 4 days of culture, osteoblast viability and morphology were both healthy. These results demonstrate that oxygen-generating nanofibers can be designed and developed to provide a short-term peroxide-based antimicrobial response while still maintaining attractive tissue-integration properties.

## Claims

### Claim 1

A composition comprising hyaluronic acid or a pharmaceutically acceptable salt thereof, and one or more inorganic peroxide for use in the prevention or treatment of wounds, or a pathological condition requiring wound healing, tissue regeneration or bone regeneration.

### Claim 2 (depends on 1)

The composition according to claim 1, wherein the peroxide is selected from calcium peroxide (CaO2), magnesium peroxide (MgO2), and/or zinc peroxide (ZnO2).

### Claim 3 (depends on 1)

The composition according to claim 1, wherein said inorganic peroxide is a combination of CaO2, MgO2 and ZnO2.

### Claim 4 (depends on 1)

The composition according to claim 1, comprising one or more additives selected from the group consisting of
a) plant extracts,
b) calcium hydroxy apatite,
c) collagen.

### Claim 5 (depends on 4)

The composition according to claim 4, wherein said plant extracts are obtained from eucalyptus, rhubarb root, clove oil, aloe vera and/or cumin.

### Claim 6 (depends on 1)

The composition according to claim 1, wherein said pathological condition is a gum disease.

### Claim 7 (depends on 6)

The composition according to claim 6, wherein said gum disease is selected from gingivitis, periodontitis or peri-implantitis.

### Claim 8 (depends on 2)

The composition according to claim 2, wherein said CaO2 is present in said composition in an amount of from about 1 mg/L to 5000 mg/L.

### Claim 9 (depends on 2)

The composition according to claim 2, wherein said CaO2 is present in the composition in an amount of from about 20 mg/L to 1000 mg/L.

### Claim 10 (depends on 2)

The composition according to claim 2, wherein said hyaluronic acid or said pharmaceutically acceptable salt thereof is present in said composition in an amount of from about 1 mg/mL to about 100 mg/mL.

### Claim 11 (depends on 4)

The composition according to claim 4, wherein said plant extract is present in said composition in an amount of from about 0.1% to about 10% by weight.

### Claim 12 (depends on 4)

The composition according to claim 4, wherein said calcium hydroxyapatite is present in said composition in an amount of from about 1% to about 30% by weight.

### Claim 13 (depends on 4)

The composition according to claim 4, wherein said calcium hydroxy apatite is present in said composition in a ratio of 0.8 to 20 for calcium/phosphate.

### Claim 14 (depends on 4)

The composition according to claim 4, wherein said collagen is present in said composition in an amount of from about 0.9% to about 25% by weight.

### Claim 15 (depends on 2)

The composition according to claim 2, wherein said ZnO2 is present in said composition in an amount of from about 1 mg/L to 10.000 mg/L.

### Claim 16 (depends on 2)

The composition according to claim 2, wherein said MgO2 is present in said composition in an amount of from about 1 mg/L to 15.000 mg/L.

### Claim 17 (depends on 1)

The composition according to claim 1, wherein the pH of the composition ranges between 6 and 8.5.

### Claim 18 (depends on 1)

The composition according to claim 1, wherein said composition is formulated as a pharmaceutical composition for topical administration.

### Claim 19 (depends on 1)

The composition according to claim 1, wherein said composition is formulated as a solution, a suspension, an emulsion, a cream, or a gel.

### Claim 20 (depends on 1)

The composition according to claim 1, wherein said composition is obtainable by applying the following processing:
(1) Dissolving a preservative in a liquid matrix;
(2) Dissolving soluble components;
(3) Suspending insoluble components;
(4) Inserting the hyaluronic acid under strong stirring.

### Claim 21 (depends on 1)

A kit for wound healing, tissue regeneration and/or bone regeneration, comprising a composition according to claim 1, and a delivery means for applying said composition into said wound, tissue or bone.

### Claim 22 (depends on 21)

The kit according to claim 21, wherein the kit is configured for delivering a composition into a gingival pocket, a periodontal pocket or a pocket resulting from peri-implantitis, said kit comprising a delivery means for topically applying said composition into a gingival pocket, periodontal pocket or pocket resulting from peri-implantitis.

### Claim 23 (depends on 21)

The kit according to claim 21, wherein the kit is configured for applying said composition on or into the oral mucosa, said kit comprising a delivery means for topically applying said composition on or into an oral mucosa.
